Anzeige
Mehr »
Mittwoch, 09.07.2025 - Börsentäglich über 12.000 News
750-Millionen-Euro-Finanzier verstärkt Forge - Sichtbares Gold befeuert Exploration
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
64 Leser
Artikel bewerten:
(0)

Surgical Sutures Market Worth $5.02 Billion by 2023

CHICAGO, October 1, 2018 /PRNewswire/ --

According to the new market research report "Surgical Suture Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread(Natural, Nylon, Prolene, Stainless Steel, Silk)), Application (Cardiac, Gynae, Ophthalmic, Orthopedic), End User (Hospital, Clinic)-Global Forecast to 2023", published by MarketsandMarkets, the global market is projected to reach USD 5.02 billion by 2023 from USD 3.86 billion in 2018, at a CAGR of 5.4% during the forecast period.

(Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Don't miss out on business opportunities in Surgical Suture Market.

Speak To Our Analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=18374832

The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the market growth. However, the presence of alternative wound care management products and growing preference for minimally invasive surgeries are some of the factors expected to limit the growth of the market to a certain extent.

By product, the suture threads segment is estimated to lead the Surgical Sutures Market in 2018.

Based on product, the surgical suture market is segmented sutures thread and automated suturing device. In 2018, the suture threads segment is expected to command the largest share of this market majorly due to the greater preference for suture threads for wound closure and their lower cost as compared to automated suturing devices.

Browse in-depth TOC on"Surgical Sutures Market"

192- Tables

33- Figures

174- Pages

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/surgical-sutures-market-18374832.html

The cardiovascular surgery segment is estimated to lead the Surgical Sutures Market during the forecast period.

Based on application, the Surgical Sutures Market is segmented into cardiovascular surgery, gynecological surgery, orthopedic surgery, ophthalmic surgery, general surgery, cosmetic surgery, and other applications. In 2018, the cardiovascular surgery segment is expected to dominate the Surgical Sutures Market. The largest share of this application segment can be primarily attributed to the large number of cardiovascular surgeries performed across the world as a result of the high prevalence of cardiovascular diseases (CVDs).

Asia to grow at the highest CAGR during the forecast period.

The Surgical Sutures Market is segmented into four major segments-North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share of the market. On the other hand, Asia is expected to register the highest CAGR during the forecast period owing to the region's growing medical tourism industry, rising prevalence of chronic diseases, and favorable reimbursement scenario. Moreover, the key surgical sutures manufacturers are also focusing on gaining a competitive edge in these high-growth markets, which is aiding the growth in Asia.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=18374832

Prominent players offering surgical sutures include Ethicon Inc. (US), B. Braun Melsungen AG (Germany), DemeTECH Corporation (US), Medtronic, plc (Ireland), Internacional Farmaceutica, S.A. De C.V. (Mexico), Sutures India Pvt. Ltd. (India), Péters Surgical (France), Smith & Nephew plc (UK), EndoEvolution, LLC (US), and Boston Scientific Corporation (US).

Browse Adjacent Markets @Medical Devices Market Research Reports & Consulting

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/surgical-sutures-market.asp

Visit Our Website: https://www.marketsandmarkets.com


© 2018 PR Newswire
Hensoldt, Renk & Rheinmetall teuer
Rheinmetall, Renk und Hensoldt haben den Rüstungsboom der letzten Jahre dominiert, doch inzwischen sind diese Titel fundamental heillos überbewertet. KGVs jenseits der 60, KUVs über 4, und das in einem politisch fragilen Umfeld mit wackelnder Haushaltsdisziplin. Für späteinsteigende Anleger kann das teuer werden.

Doch es gibt Alternativen, die bislang unter dem Radar fliegen; solide bewertet, operativ stark und mit Nachholpotenzial.

In unserem kostenlosen Report zeigen wir dir, welche 3 Rüstungsunternehmen noch Potenzial haben und wie du von der zweiten Welle der Zeitenwende profitieren kannst, ohne sich an überhitzten Highflyer zu verbrennen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders vom weltweiten Aufrüsten profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.